Blog
Guias práticos para protocolos de peptídeos.
Conteúdo educativo sobre acompanhamento, matemática de dosagem, armazenamento, exames de sangue e desenho de protocolo. Todo post é revisado por uma pessoa e livre de aconselhamento médico.
Os guias em si estão escritos em inglês.
Todos os 143 guias de peptídeos
Busque pelo nome ou toque em um benefício para achar o peptídeo certo para o que você quer.
Filtrar por benefício
Mostrando 142 de 142 guias de peptídeos.
MK-677 (Ibutamoren): A Tracking Guide for an Oral GH Secretagogue
A measured, harm-reduction look at MK-677, what it actually does to GH and IGF-1, and the daily signals and bloodwork worth watching.
Bom para
Oral Semaglutide 25 mg: A Tracking Guide for the Wegovy Pill
A neutral, harm-reduction guide to the oral semaglutide weight-management pill, its strict dosing rules, and what to monitor.
Bom para
Ostarine (MK-2866): A Tracking Guide for the Most-Studied SARM
A neutral, harm-reduction look at ostarine, why it is the mildest of the SARMs, and what to monitor given it still suppresses natural hormones.
Bom para
CagriSema: A Tracking Guide for a Cagrilintide and Semaglutide Combination
A harm-reduction look at CagriSema, an investigational amylin-plus-GLP-1 combination not yet approved, and what would be worth tracking.
Bom para
Ligandrol (LGD-4033): A Tracking Guide for a Potent Mass-Building SARM
A harm-reduction look at ligandrol, why its strength comes with strong hormonal suppression, and the monitoring that actually matters.
Bom para
Mazdutide: A Tracking Guide for a Glucagon and GLP-1 Dual Agonist
A neutral, harm-reduction guide to mazdutide, a dual glucagon/GLP-1 agonist approved in China, and what to monitor.
Bom para
RAD-140 (Testolone): A Tracking Guide for a Strong Lean-Mass SARM
A harm-reduction look at RAD-140, its strong anabolic effect, the reported liver-injury signals, and what to monitor closely.
Bom para
Survodutide: A Tracking Guide for a GLP-1 and Glucagon Dual Agonist
A harm-reduction look at survodutide, an investigational GLP-1/glucagon agonist with obesity and MASH data, not yet approved.
Bom para
Cardarine (GW-501516): A Tracking Guide for a PPAR-Delta Agonist
A candid, harm-reduction look at cardarine, its endurance and fat-oxidation effects, and the rodent carcinogenicity signal that ended its development.
Bom para
Amycretin: A Tracking Guide for a GLP-1 and Amylin Agonist
A neutral, harm-reduction guide to amycretin, an investigational GLP-1/amylin agonist in oral and injectable forms, entering Phase 3.
Bom para
Andarine (S4): A Tracking Guide for an Older Cutting SARM
A harm-reduction look at andarine, its use in cutting phases, and the reversible vision side effect that sets it apart from other SARMs.
Bom para
VK2735: A Tracking Guide for a GIP and GLP-1 Dual Agonist
A harm-reduction look at VK2735, an investigational GIP/GLP-1 agonist in oral and injectable Phase 3 programs, not yet approved.
Bom para
YK-11: A Tracking Guide for a Steroidal Myostatin-Claim Compound
A harm-reduction look at YK-11, a steroidal compound sold as a SARM with myostatin-inhibition claims, and why the human evidence is essentially absent.
Bom para
Pemvidutide: A Tracking Guide for a GLP-1 and Glucagon Agonist
A neutral, harm-reduction guide to pemvidutide, an investigational GLP-1/glucagon agonist noted for lean-mass sparing and MASH data.
Bom para
Stenabolic (SR9009): A Tracking Guide for a REV-ERB Exercise Mimetic
A harm-reduction look at SR9009, its exercise-mimetic claims, and the poor oral bioavailability that undercuts most real-world use.
Bom para
Bimagrumab: A Tracking Guide for an Activin Receptor Antibody
A harm-reduction look at bimagrumab, an investigational antibody that lowers fat while preserving or adding muscle, studied with semaglutide.
Bom para
Enclomiphene: A Tracking Guide for a Fertility-Preserving SERM
A measured, harm-reduction look at enclomiphene, why it is used instead of exogenous testosterone, and the bloodwork that tells you whether it is working.
Bom para
Superdrol (Methasterone): A Tracking Guide for a Harsh Oral Steroid
A harm-reduction look at methasterone, a potent and markedly hepatotoxic oral steroid, and the monitoring that matters most if someone has already decided to use it.
Bom para
Cabergoline: A Tracking Guide for a Prolactin-Lowering Dopamine Agonist
A cautious, harm-reduction look at cabergoline, why it is used to manage prolactin, and the cardiac risk that has to be taken seriously.
Bom para
Halotestin (Fluoxymesterone): A Tracking Guide for a Potent Oral Androgen
A harm-reduction look at fluoxymesterone, a strong oral steroid used pre-competition for strength and aggression, with honest framing of its liver and lipid risks.
Bom para
Raloxifene: A Tracking Guide for a Gynecomastia-Focused SERM
A measured, harm-reduction look at raloxifene, why it is often preferred for treating gynecomastia, and the clotting risk to watch.
Bom para
Proviron (Mesterolone): A Tracking Guide for an Oral DHT Derivative
A measured look at mesterolone, a weakly anabolic oral DHT derivative used as an adjunct to lower SHBG and support libido, and what is worth tracking.
Bom para
Toremifene: A Tracking Guide for a Tamoxifen-Like SERM
A measured, harm-reduction look at toremifene, how it compares to tamoxifen, and what to monitor when it is used for gyno control or PCT.
Bom para
Trestolone (MENT): A Tracking Guide for a Potent 19-Nor Injectable
A harm-reduction look at trestolone, a very potent nandrolone-like injectable that is strongly suppressive and aromatizes to a potent estrogen, and what to monitor.
Bom para
Finasteride and Dutasteride: A Tracking Guide for 5-Alpha-Reductase Inhibitors
A balanced, harm-reduction look at finasteride and dutasteride, how they cut DHT for hair loss, and the honest tradeoffs including post-finasteride syndrome.
Bom para
DHB (Dihydroboldenone): A Tracking Guide for 1-Testosterone
A harm-reduction look at dihydroboldenone, a non-aromatizing injectable anabolic notorious for post-injection pain, and the monitoring worth doing.
Bom para
Testosterone Undecanoate: A Tracking Guide for Long-Ester and Oral TRT
A measured, harm-reduction look at testosterone undecanoate in both its very long-ester injectable and oral forms, and the bloodwork that actually matters.
Bom para
Clenbuterol: A Harm-Reduction Tracking Guide for a Beta-2 Agonist
A cautious, harm-reduction look at clenbuterol, a stimulant thermogenic with real cardiac risk, and what to monitor if you have already decided to use it.
Bom para
T3 (Liothyronine): A Tracking Guide for a Synthetic Thyroid Hormone
A measured look at liothyronine (T3), why it is used for fat loss, and the muscle and cardiac risks that come with suppressing your own thyroid.
Bom para
Rapamycin (Sirolimus): A Tracking Guide for an mTOR Inhibitor
An evidence-aware look at rapamycin, the headline off-label longevity drug, what the human data actually shows, and what to monitor on intermittent dosing.
Bom para
Urolithin A: A Tracking Guide for a Mitophagy Activator
An evidence-aware look at urolithin A, a gut-derived metabolite with human muscle and endurance data, sold as a well-tolerated supplement.
Bom para
Spermidine: A Tracking Guide for a Polyamine Autophagy Inducer
An evidence-aware look at spermidine, a dietary polyamine linked to autophagy and longevity signals, sold as a wheat-germ-derived supplement.
Bom para
Fisetin: A Tracking Guide for a Flavonoid Senolytic
An evidence-aware look at fisetin, a plant flavonoid used in intermittent senolytic protocols, and why the human data is still mostly preliminary.
Bom para
DNP (2,4-Dinitrophenol): A Harm-Reduction Tracking Guide for a Dangerous Uncoupler
A blunt harm-reduction guide to DNP, a mitochondrial uncoupler with a narrow margin between fat loss and death, for people who have already obtained it.
Bom para
Racetams (Piracetam / Aniracetam / Phenylpiracetam): A Tracking Guide for the Foundational Nootropic Class
A measured look at the classic racetam nootropics, how the common variants differ, and how to track whether they do anything for you.
Bom para
SNAP-8 (Acetyl Octapeptide-3): A Tracking Guide for the Topical Botox-Mimetic Peptide
Why SNAP-8 is a cosmetic ingredient rather than an injectable, and how to track whether it actually softens expression lines.
Bom para
Matrixyl (Palmitoyl Pentapeptide-4): A Tracking Guide for the Collagen-Signal Peptide
A measured look at Matrixyl, the topical collagen-stimulating peptide, and how to track whether it does anything for your skin.
Bom para
Follistatin / ACE-031: A Tracking Guide for the Myostatin-Inhibitor Class
A cautious, harm-reduction look at follistatin and ACE-031, why the human evidence is thin, and what to log if you use them anyway.
Bom para
Dihexa: A Tracking Guide for a Preclinical Nootropic
A measured look at Dihexa, why almost all of the evidence is in animals, and what a careful self-experimenter would actually log.
Bom para
Cerebrolysin: A Tracking Guide and an Honest Look at the Evidence
What Cerebrolysin is, why the stroke evidence is genuinely mixed, and the metrics worth logging if you use it.
Bom para
PE-22-28: A Tracking Guide for a Research-Stage Antidepressant Peptide
A spadin analog that targets TREK-1. What the mechanism implies, why it is research-only, and what to log.
Bom para
NA-Semax-Amidate: A Tracking Guide for the Long-Acting Semax Variant
How N-acetyl Semax amidate differs from plain Semax, why people use it, and the focus and mood metrics worth logging.
Bom para
NA-Selank-Amidate: A Tracking Guide for the Long-Acting Selank Variant
The amidated, longer-lasting Selank analog. What it is used for, how it differs, and the anxiety and focus metrics worth tracking.
Bom para
Argireline (Acetyl Hexapeptide-8): A Tracking Guide for the Topical Peptide
Why Argireline is a cosmetic, not a Botox replacement, and how to track whether it is actually doing anything for your skin.
Bom para
Testosterone Enanthate: A Tracking Guide for a Long-Ester Androgen
A measured, harm-reduction look at testosterone enanthate, what to monitor on TRT or a cycle, and the bloodwork that actually matters.
Bom para
Testosterone Cypionate: A Tracking Guide for TRT and Beyond
Cypionate behaves almost identically to enanthate. Here is what to monitor, the bloodwork that matters, and the mistakes to avoid.
Bom para
Testosterone Propionate: A Tracking Guide for the Short Ester
Propionate clears fast, which means frequent injections and sharper fluctuations. Here is what that changes about tracking.
Bom para
Sustanon 250: A Tracking Guide for the Testosterone Blend
A four-ester testosterone blend with a tricky release curve. Why the mixed esters complicate tracking and what to monitor.
Bom para
Nandrolone Decanoate: A Tracking Guide and Risk Overview
A long-ester 19-nortestosterone with a real medical history and serious suppression. What to monitor, including the things people miss.
Bom para
Nandrolone Phenylpropionate: A Tracking Guide for the Short-Ester Nandrolone
NPP is nandrolone on a faster ester. Same compound, same risks, more frequent injections. What to track.
Bom para
Trenbolone Enanthate: A Tracking Guide for a High-Risk Anabolic
A potent 19-nor anabolic with a heavy side-effect load. This is a harm-reduction tracking guide, not an endorsement.
Bom para
Trenbolone Acetate: A Tracking Guide for the Fast-Acting Variant
Same potent, high-risk compound as the enanthate version, on a short ester. What the faster clearance changes for tracking.
Bom para
Boldenone Undecylenate: A Tracking Guide for a Veterinary Anabolic
A long-acting veterinary steroid sometimes used by humans. What it does, the slow timeline, and what to monitor.
Bom para
Drostanolone Propionate (Masteron): A Tracking Guide for the Short Ester
A DHT-derived anabolic associated with cutting and "hardening." What that means, what it does not do, and what to monitor.
Bom para
Drostanolone Enanthate: A Tracking Guide for the Long-Ester Masteron
The longer-acting version of Masteron. Same DHT-derived profile, fewer injections, slower kinetics. What to track.
Bom para
BPC-157: A Beginner's Guide to Dosing and Tracking
What BPC-157 is, how protocols are typically structured, what to track during a cycle, and the common mistakes self-experimenters make.
Bom para
Methenolone Enanthate (Primobolan): A Tracking Guide for a "Mild" Anabolic
Often called gentle, but still suppressive and not risk-free. What "mild" actually means and what to monitor.
Bom para
Oxandrolone (Anavar): A Tracking Guide for a Mild Oral Anabolic
An oral with a real medical history and a gentle reputation - but real liver, lipid, and suppression concerns. What to monitor.
Bom para
Methandrostenolone (Dianabol): A Tracking Guide for the Classic Oral
Fast mass and strength, heavy water retention, and real liver and blood-pressure costs. What to monitor on this classic oral.
Bom para
Stanozolol (Winstrol): A Tracking Guide and Lipid Warning
A DHT-derived steroid known for a "dry" look - and for hammering cholesterol and joints. What to monitor closely.
Bom para
Oxymetholone (Anadrol): A Tracking Guide for a Potent Oral
Big, fast mass and red-cell effects with heavy liver, blood-pressure, and side-effect load. What to monitor carefully.
Bom para
Turinabol: A Tracking Guide for a Mild Oral Anabolic
A non-aromatising oral known for steady lean gains and a long detection window. What to track and the liver and lipid costs.
Bom para
Tamoxifen: A Tracking Guide for the SERM
A breast-cancer drug with boxed warnings, sometimes used off-label for gynecomastia or HPTA recovery. What to monitor and respect.
Bom para
Clomiphene (Clomid): A Tracking Guide for the Fertility SERM
A SERM used for fertility and to raise testosterone via LH and FSH. What to track, including the visual-disturbance warning.
Bom para
Anastrozole: A Tracking Guide for the Aromatase Inhibitor
A non-steroidal AI that lowers estrogen. Useful in the right context, harmful if you over-suppress. What to monitor.
Bom para
Exemestane: A Tracking Guide for the Steroidal AI
A steroidal aromatase inhibitor that binds irreversibly. How it differs from anastrozole and what to monitor.
Bom para
Letrozole: A Tracking Guide for a Potent Aromatase Inhibitor
The strongest of the common AIs - and the easiest to crash estrogen with. Why low doses and labs matter most here.
Bom para
5-Amino-1MQ: A Tracking Guide for an NNMT Inhibitor
What 5-Amino-1MQ is, why it is studied as a metabolic compound, and how a self-experimenter can structure tracking around very limited human data.
Bom para
GLP-2 TZ (Teduglutide): A Tracking Guide for the Gut-Curious
A pragmatic look at teduglutide, the approved GLP-2 analog, and how a self-experimenter might track gut-related outcomes.
Bom para
Insulin (Human): A Tracking Guide and a Strong Warning
Why insulin is the most dangerous peptide on the menu, and how serious users approach tracking when medically indicated.
Bom para
Mechano Growth Factor (MGF): What the Splice Variant Story Actually Says
A pragmatic tracking guide for MGF, the muscle-damage-responsive splice variant of IGF-1.
Bom para
CJC-1295 with DAC: Tracking the Long-Acting GHRH Analog
A practical tracking guide for the DAC version of CJC-1295, with weekly dosing rationale and IGF-1 expectations.
Bom para
Noopept: A Tracking Guide for a Synthetic Nootropic
What Noopept is, how oral protocols are typically structured, and how to track cognitive effects with task-based metrics instead of vibes.
Bom para
Salmon Calcitonin: A Tracking Guide for Bone and Calcium Markers
How to track salmon calcitonin use for bone density, calcium, and symptom response without overinterpreting short-term data.
Bom para
Thymalin: A Tracking Guide for an Older-Population Immune Peptide
What Thymalin is, where the Khavinson research comes from, and how to track a cycle if you choose to run one.
Bom para
AHK-Cu: A Tracking Guide for a Copper Tripeptide
What AHK-Cu is, how it compares to GHK-Cu, and how to track hair, scalp, and skin changes if you choose to use it.
Bom para
Glutathione: A Tracking Guide for the Master Antioxidant
How glutathione works, route differences, and what a self-experimenter should actually measure.
Bom para
Ipamorelin: A Standalone Tracking Guide
A pragmatic log structure for ipamorelin used on its own, separate from the common CJC-1295 stack.
Bom para
Melanotan I (Afamelanotide): The Slower, Cleaner Cousin
How MT-1 differs from MT-II in pharmacology, side effects, and what to actually track.
Bom para
NR (Nicotinamide Riboside): Tracking a NAD+ Precursor
What NR is, how it compares to NMN, and how to track realistic outcomes from a vitamin B3 derivative marketed for cellular aging.
Bom para
CJC-1295 No-DAC (Mod GRF 1-29): Pulsatile GHRH Tracking
How the short-acting GHRH analog works, why it mimics natural GH pulses, and what to track when using it.
Bom para
Selank Alone: A Focused Tracking Guide for the Anxiolytic Heptapeptide
A dedicated tracking framework for Selank used on its own, separating its anxiolytic signal from placebo and lifestyle noise.
Bom para
Thymosin Alpha-1 (TA1): A Tracking Guide for an Approved Immune Peptide
What Thymosin Alpha-1 is, its approval history as Zadaxin, typical protocol shapes, and how to track an immune-focused cycle.
Bom para
Oxytocin: A Tracking Guide for a Social Neuropeptide
What oxytocin is, how intranasal protocols appear in research, and how to track behavioral effects honestly given how messy the literature is.
Bom para
AOD-9604: A Tracking Guide for an hGH Fragment
What AOD-9604 is, why it failed in obesity trials, and how to track fat-loss protocols if you choose to use it.
Bom para
Gonadorelin (GnRH): A Tracking Guide for HPG Axis Support
How gonadorelin is used alongside TRT and fertility protocols, and what to actually measure.
Bom para
Melatonin: Most People Take Ten Times Too Much
A precision-dosing and sleep-tracking guide for melatonin, the most over-dosed sleep aid on the shelf.
Bom para
CJC-1295 No-DAC + Ipamorelin Pre-Blend: Practical Tracking
What to know about using a pre-mixed CJC-1295/ipamorelin blend versus separate vials, and how it affects your tracking.
Bom para
Kisspeptin-10: A Tracking Guide for the Upstream Hormone Signal
How to log a kisspeptin-10 protocol focused on reproductive and HPG-axis endpoints.
Bom para
Semax Alone: Tracking Focus and Cognitive Effects of the ACTH Fragment
A focused tracking guide for Semax used solo, with an emphasis on separating real cognitive signal from caffeine and sleep effects.
Bom para
Thymosin Beta-4 (TB4): The Parent Molecule, Not the TB-500 Fragment
What full-length TB4 is, how it differs from the TB-500 fragment, and how to track a cycle if you choose to run the parent peptide.
Bom para
TB-500 + BPC-157: When to Stack and When to Cycle Separately
A practical decision framework for the most common peptide stack in recovery-focused protocols. Goals, timelines, and how to track stacks cleanly.
Bom para
P21: Tracking a Speculative CNTF-Derived Research Peptide
What P21 is, why the human evidence is essentially zero, and how to track it honestly if you choose to experiment at all.
Bom para
HCG: A Tracking Guide for TRT and Fertility Contexts
A measured look at HCG, what it actually does, and the metrics worth tracking.
Bom para
Metformin: The Old Drug in the Longevity Conversation
A tracking guide for metformin that takes its prescription status and side effects seriously.
Bom para
Thyrotropin-Releasing Hormone (TRH): A Tracking Guide
What TRH is, its clinical contexts, and what to track honestly if you are exploring this hypothalamic tripeptide.
Bom para
ARA-290 (Cibinetide): A Tracking Guide for Tissue Protection and Neuropathic Pain
What ARA-290 is, why it was developed for small-fiber neuropathy, and how to track pain, sensation, and inflammatory markers if you use it.
Bom para
Dulaglutide (Trulicity): A Practical Tracking Guide
Weekly GLP-1 receptor agonist with a clean titration shape — what to track and how it compares to semaglutide and tirzepatide.
Bom para
Sermorelin: Tracking the Full-Length GHRH Analog
A tracking guide for sermorelin, the 29-amino-acid GHRH analog, with realistic expectations for sleep, recovery, and IGF-1 changes.
Bom para
PEG-MGF: Tracking a Long-Acting Mechano Growth Factor
What PEG-MGF is, how PEGylation changes the dosing schedule versus regular MGF, and how that changes what you track and when.
Bom para
Hexarelin: A Tracking Guide With a Desensitization Warning
The strongest of the older GHRPs has tradeoffs that show up fast. Here is how to track them.
Bom para
MOTS-c: A Mitochondrial Peptide With Real Biology and Modest Human Data
What MOTS-c does, what it might do in humans, and how to track it honestly.
Bom para
Tirzepatide: A Tracking Guide for the Dual GLP-1 / GIP Titration
A focused guide to tracking a tirzepatide protocol — the titration, the unique GIP-side effects, sulfur burps, and what to log week-over-week.
Bom para
GHK-Cu: Tracking Outcomes for Skin, Hair, and Recovery
A practical guide to tracking GHK-Cu protocols — what to measure, what to photograph, and what the realistic timelines look like.
Bom para
B7-33: A Tracking Guide for a Single-Chain Relaxin Analog
What B7-33 is, why it is studied in fibrosis and cardiac research, and why human tracking is currently very limited.
Bom para
KPV: A Tracking Guide for the Anti-Inflammatory Tripeptide
How to log KPV use across gut, skin, and inflammatory endpoints without overclaiming.
Bom para
Sermorelin / Ipamorelin Blends: What the Pre-Mix Actually Costs You
A practical look at pre-mixed sermorelin/ipamorelin blends — the GHRH plus GHRP rationale and the tracking tradeoffs of using one syringe.
Bom para
Humanin: A Tracking Guide for an Early-Stage Mitochondrial Peptide
A small peptide encoded in mitochondrial DNA with intriguing but very early evidence.
Bom para
NAD+ Direct: IV, Subcutaneous, and the Question of Whether You Need Any of It
A tracking guide for direct NAD+ supplementation that takes the cost and evidence seriously.
Bom para
Tracking Semaglutide: Dose Titration and Side Effects
A pragmatic guide to logging a semaglutide titration. What to capture daily, weekly, and at every dose increase.
Bom para
Exenatide (Byetta and Bydureon): Tracking the Original GLP-1
The first-in-class GLP-1 receptor agonist, derived from Gila monster venom — twice-daily and weekly versions tracked.
Bom para
Triptorelin: A Tracking Guide for a GnRH Agonist
What triptorelin is, its clinical uses, and what self-experimenters tracking off-label post-cycle restarts should log honestly.
Bom para
BPC-157 / TB-500 Blend: A Tracking Guide for Pre-Mixed Recovery Stacks
Why some users choose a pre-mixed BPC-157 and TB-500 blend, what you give up in flexibility, and how to track a stacked recovery protocol.
Bom para
L-Carnitine: A Tracking Guide for Energy and Fat Oxidation
How to log L-carnitine use across oral, injectable, and IV protocols with realistic expectations.
Bom para
IGF-1 DES (1-3): A Tracking Guide for a Truncated IGF Variant
A short-acting IGF-1 variant used in research and bodybuilding circles. Here is how to track it honestly.
Bom para
NADH: The Reduced Form, Oral Route, and What It Might Actually Help
A focused tracking guide for oral NADH supplementation in fatigue, cognition, and Parkinson disease contexts.
Bom para
Somatropin (HGH): A Tracking Guide with Serious Safety Emphasis
A careful tracking guide for recombinant human growth hormone, focused on what to monitor when using a prescription compound with real metabolic consequences.
Bom para
Vasopressin (AVP / ADH): A Tracking Guide for a Pituitary Hormone
What vasopressin is, where it is used clinically, and the honest framing for any self-experimenter considering tracking it.
Bom para
GHRP-2: Tracking a Classic GH Secretagogue
A practical tracking guide for GHRP-2, a ghrelin mimetic often paired with GHRH analogs, with attention to cortisol and prolactin.
Bom para
Cagrilintide: A Tracking Guide for a Long-Acting Amylin Analog
What cagrilintide is, why it is being studied with semaglutide as CagriSema, and how to track appetite, weight, and tolerability.
Bom para
Pinealon: Tracking a Short Khavinson Peptide
What Pinealon is, where it sits in the Khavinson peptide family, and how to track its proposed cognitive and stress effects honestly.
Bom para
SS-31 (Elamipretide): Tracking a Mitochondria-Targeting Tetrapeptide
A tracking guide for SS-31/elamipretide, the cardiolipin-binding peptide studied in mitochondrial disease and heart failure.
Bom para
Liraglutide: A Tracking Guide for the Daily GLP-1
How to log a liraglutide titration and decide whether the daily-injection tradeoff makes sense for you.
Bom para
Vilon: A Tracking Guide for a Short Khavinson Dipeptide
What Vilon is, where the research comes from, realistic expectations, and how to track a course if you choose to run one.
Bom para
GHRP-6: Tracking the Appetite-Forward GH Secretagogue
A practical tracking guide for GHRP-6, with attention to the strong hunger response and how it fits a bulking phase.
Bom para
IGF-1 LR3: A Tracking Guide With a Hypoglycemia Warning
Long-acting IGF-1 analog with extended half-life. What to measure and what to watch out for.
Bom para
NMN: A Precursor With Big Claims and Measurable Realities
A tracking guide for NMN supplementation focused on what is actually measurable in humans.
Bom para
Calcitonin: A Tracking Guide for a Calcium-Regulating Peptide
What calcitonin is, where it is used clinically for bone and calcium disorders, and how to track a calcitonin protocol responsibly.
Bom para
TB-500 Alone: Tracking the Thymosin Beta-4 Fragment for Recovery
A focused tracking guide for TB-500 used by itself, separating its slower recovery signal from BPC-157 and confounders.
Bom para
Wolverine Blend vs Plain BPC-157 / TB-500: A Tracking Perspective
What the "Wolverine" branding actually is, how it differs from a plain BPC-157 / TB-500 blend on paper, and how to track either honestly.
Bom para
Retatrutide: Tracking a Triple-Agonist Weight-Loss Compound
What Retatrutide is, how the GLP-1 / GIP / glucagon mechanism differs from single-agonists, and how to track titration and side effects honestly.
Bom para
GLOW Blend (GHK-Cu / BPC-157 / TB-500): Tracking a Multi-Peptide Stack
How to think about and track proprietary multi-peptide blends marketed as one product, with honest limits on attribution.
Bom para
LL-37: A Tracking Guide for the Cathelicidin Peptide
How to log LL-37 use across antimicrobial and inflammation endpoints, with honest notes on the limited human data.
Bom para
Ipamorelin and CJC-1295: A Practical Tracking Guide
Two growth-hormone-releasing peptides that are usually used together. How they differ, how protocols are structured, and what to track.
Bom para
Melanotan II: Tracking the "Tanning Peptide" Properly
How to track a Melanotan II loading and maintenance protocol. Dosing patterns, side-effect logging, photos, and the realistic timeline for pigment change.
Bom para
Tirzepatide vs Semaglutide: How to Track the Differences
The two leading GLP-1 protocols compared by what they ask of the user, what to track, and how the side-effect profiles differ across a titration.
Bom para
Tesamorelin: A Tracking Guide for Visceral-Fat Protocols
What tesamorelin is, how protocols are structured, what to measure if you want to evaluate effects on visceral fat, energy, and sleep.
Bom para
HGH Fragment 176-191: A Fat-Loss Protocol Tracking Guide
What HGH fragment 176-191 is, why protocols are structured the way they are, and the daily/weekly metrics that actually reveal whether it works for you.
Bom para
Epitalon: Tracking a Longevity-Focused Protocol
Epitalon protocols last days, not weeks, and effects accumulate across cycles. Here is what to track if you want personal data that compounds over years.
Bom para
Selank and Semax: Tracking Nootropic Peptides
How to track two of the most popular Russian-developed cognitive peptides. Daily dosing, objective cognitive metrics, and how to avoid fooling yourself.
Bom para
DSIP: How to Track the "Delta Sleep" Peptide
DSIP claims to improve deep sleep, recovery, and pain modulation. Here is the tracking protocol that turns vague sleep impressions into real data.
Bom para
PT-141 (Bremelanotide): Tracking Doses and Side Effects
PT-141 has a distinctive on/off effect profile that needs a different tracking pattern. What to log, when to log it, and the common attribution errors.
Bom para